Alambic Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,515
Closed -$202K 318
2019
Q3
$202K Sell
2,515
-32
-1% -$2.56K 0.15% 212
2019
Q2
$204K Sell
2,547
-125
-5% -$9.57K 0.13% 235
2019
Q1
$212K Sell
2,672
-336
-11% -$25.1K 0.09% 276
2018
Q4
$219K Buy
+3,008
New +$212K 0.09% 246
2017
Q4
Sell
-13,750
Closed -$840K 496
2017
Q3
$840K Sell
13,750
-9,809
-42% -$595K 0.09% 297
2017
Q2
$1.44M Sell
23,559
-27,982
-54% -$1.7M 0.18% 195
2017
Q1
$3.13M Buy
+51,541
New +$3.13M 0.38% 59

Other funds holding MRK

Alambic Investment Management's MRK Position: Q4 2019 in Review

Alambic Investment Management sold out of Merck (MRK) in Q4 2019, closing a stake of 2,515 shares — an estimated $202K sold.

Alambic Investment Management first reported a position in MRK in Q1 2017 and held it in 7 quarters. The position peaked at $3.13M in Q1 2017. 2,536 funds tracked by Wall St. Rank hold MRK as of Q4 2019.

  • Alambic Investment Management reported no remaining Merck position as of Q4 2019 after selling out during the quarter.
  • Alambic Investment Management sold 2,515 Merck shares in Q4 2019, an estimated $202K.
  • Alambic Investment Management first reported a position in Merck in Q1 2017 and held it in 7 quarters.
  • Alambic Investment Management's Merck position peaked at $3.13M in Q1 2017.
  • 2,536 funds tracked by Wall St. Rank held Merck as of Q4 2019.

Based on Alambic Investment Management's 13F filing for Q4 2019, filed 12 Feb 2020.